Clinical Trial Details
— Status: Terminated
Administrative data
NCT number |
NCT03254264 |
Other study ID # |
2015-A00696-43 |
Secondary ID |
|
Status |
Terminated |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 29, 2017 |
Est. completion date |
March 25, 2022 |
Study information
Verified date |
March 2022 |
Source |
Hôpital le Vinatier |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The Early start Denver model (Rogers, 2010; Dawson, 2010) is a developmental and behavioral
model that aim to enhance socio-comunicative abilities and also global development of
children with Autism spectrum disorder (ASD). The purpose of this study is to identify
changes in neurocognitive profile of children population with ASD receiving Early Start
Denver Model (ESDM) applied 12 hours per week in comparison to children receiving other
interventions. That is a study proposed to children with ASD and their families that
participate already to a randomized control study called IDEA registered on
clinicaltrials.gov NCT02608333.
the investigators hypothesized that ESDM would increase social cognition, reduce shifting
attention time and increase preference for unpredictable stimuli.
Description:
IDEA is a multicenter (4 centers in France and 1 center in Belgium), randomized, controlled,
single blind trial using a modified Zelen design .It concerns children with ASD aged 15 to 36
months without severe neurological or physical disorder and living in the proximity of one
the early intervention units. After diagnostic, Children will be included in a longitudinal
cohort with the consent of the parents. Sixty children will be drawn lots among 180 children
of the cohort and will be included in an ESDM intervention with the consent of the parents.
Two groups will be compared: an experimental group of 60 children receiving 12 hours a week
of ESDM intervention delivered by trained therapists during 2 years and a control group of
120 children receiving typical heterogeneous 'as-usual' intervention proposed by
professionals and public services over the same period. In IDEA development of communication
and social interactions and global developmental of all the children will be measured at
different time points (at baseline (t0), after 1 year (t1), after 2 years( t2)) over the two
years through standardized tests such as Autism diagnostic observation Schedule (ADOS-2),
Mullen Scales of Early Learning (MSEL) and the Vineland Adaptive Behavior Scale (VABS-2).
Children will be included in this second study called IDEA-EYE with parents' consent. Then,
preference for biological motion and social scene, shifting attention time and preference for
sameness will be measure in both groups with an Eye-tracker Tobii TX 300 at t0,t1 and t2.
These measures will also be collected in a group of children without ASD at t0,t1 and t2.
the investigators expect, as primary criteria, a significant superior time spend on
biological motion in ESDM group versus control group after 2 years of treatment. the
investigators also expect a significant superior orientation toward eyes in complex social
scenes, an inferior shifting attention time and a superior preference for unpredictable
stimuli in ESDM group versus ASD control group after 2 years. the investigators also expect
that ESDM group would have time spend on biological motion, orientation toward eyes in
complex scenes, shifting attention time and preference for unpredictable stimuli comparable
to children without ASD after 2 years.
This study would allow better understanding of ESDM active principles.